Questions & Answers

Q&A MNL Group - Clinically Proven Eye Hydration & Cellular Protection

A standardized Maqui extract rich in delphinidins — the world’s most powerful antioxidant molecules — clinically validated to support tear fluid balance and ocular comfort.

maqui-berry-supplement

  • MNL Group is a Chilean nutraceutical company specializing in standardized Maqui Berry (Aristotelia chilensis) extracts for human and animal health, founded in 2010 as a spin-off from a scientific consortium. MNL Group's ingredient portfolio includes Delphinol® for metabolic and skin health, MaquiBright® for eye health, and Futerpenol® for aquaculture and animal nutrition. All three are supplied as B2B ingredients to nutraceutical brands, supplement manufacturers, functional food companies, and animal health producers worldwide, combining sustainable natural sourcing from Patagonia with clinical validation.

  • Maqui Berry (Aristotelia chilensis) contains the highest known concentration of delphinidins among all documented fruits — up to 1,260 mg per 100 g of raw fruit — giving it an antioxidant capacity of 28,200 ORAC units, approximately 7 times that of açaí and 9 times that of goji. Maqui Berry is a wild fruit native to the temperate forests of Southern Chile, in Patagonia. Delphinidins are a subclass of anthocyanins with strong biological activity, including the capacity to neutralize multiple reactive oxygen species, modulate inflammatory pathways, and interact with receptors involved in glucose metabolism. This profile has made Maqui Berry the focus of more than 15 years of research at MNL Group, resulting in three patented ingredients and over 30 published studies.

  • MNL Group's Maqui Berry is wild-harvested in the temperate forests of Southern Chile, in Patagonia, where the fruit grows naturally. It is hand-collected by local families and harvesting communities during a short seasonal window, typically between January and March. MNL Group operates under responsible wild harvesting criteria that protect plant regeneration, soil stability, and biodiversity, and participates in the UEBT (Union for Ethical BioTrade) Field Verification Programme, which independently assesses social, economic, and environmental conditions across the supply chain.

  • MNL Group's extracts are produced through a patented process that concentrates and standardizes the active compounds in Maqui Berry. After harvest, fresh berries are stored under controlled freezing conditions to preserve anthocyanin integrity, then processed so that each batch of Delphinol® and MaquiBright® meets a minimum of 35% total anthocyanins and 25% delphinidins, ensuring consistent potency. Quality verification includes HPLC fingerprinting for anthocyanin quantification, ORAC 5.0 testing for antioxidant capacity, and screening for microbiological contaminants, heavy metals, and pesticides. The entire process operates under GMP, ISO 9001, and HACCP standards.

  • MNL Group's production process adheres to GMP, ISO 9001, and HACCP standards, with full analytical characterization per batch including anthocyanin profile by HPLC, antioxidant capacity by ORAC 5.0, and safety screening for microbiological contaminants, heavy metals, and pesticide residues. MNL Group also participates in the UEBT Field Verification Programme for responsible sourcing. Technical documentation including certificates of analysis, safety data sheets, and regulatory dossiers is available upon request.

  • Delphinol® and MaquiBright® are both standardized Maqui Berry extracts with the same specification (≥35% total anthocyanins, ≥25% delphinidins), but they are developed, patented, and clinically validated for distinct applications. Delphinol® is the metabolic and antioxidant ingredient, with clinical evidence in glucose metabolism, lipid profile, oxidative stress, and skin vitality. MaquiBright® is the eye health ingredient, with clinical evidence in tear fluid production, dry eye symptom reduction, and ocular oxidative protection. The two are sometimes used together in formulations targeting multiple health outcomes.

  • MNL Group's ingredients are used by more than 35 brands across North America, Latin America, Europe, and Asia, in dietary supplements and nutraceuticals, functional beverages, beauty-from-within and skin health products, eye health formulations, and aquaculture nutrition. The primary B2B markets for human health ingredients are the United States and Asia, while Animal Health serves the aquaculture industry primarily in Chile, Norway, Brazil, and Canada.

  • MNL Group's patented extracts — Delphinol® and MaquiBright® — are used by supplement and functional food brands around the world. If you are a consumer looking for products formulated with our ingredients, you can find an updated list of brands and products at mnl-group.com/en/find-products.

  • MNL Group provides B2B partners with full technical support throughout the ingredient integration process, including certificates of analysis, safety documentation, regulatory dossiers adapted to target markets, and scientific literature covering the clinical evidence for each ingredient. The team can also provide guidance on clinically supported dosage ranges, ingredient compatibility, and labeling considerations. To initiate a conversation, request samples, or access technical documentation, contact our team at mnl-group.com/contact.

⚠️ These products are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the U.S. Food and Drug Administration or equivalent regulatory authorities. The information provided here is for educational and business purposes only. Delphinol® and MaquiBright® are nutraceutical ingredients supplied to manufacturers, not finished consumer products. Health claims for finished products are the responsibility of the manufacturer and must comply with the regulations of the market in which they are sold. Clinical results refer to specific standardized extracts studied under defined conditions.